MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$1,150,152
EPS
-$0.03
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
NaN NaN NaN 0
General and administrative expenses
578,698 5,328,284 904,346 1,049,903
Research and development expenses
524,781 496,543 412,639 496,197
Total operating costs
1,103,479 5,824,827 1,316,985 1,546,100
Interest income
44,909 51,820* 15,697 NaN
Other expense
NaN -24,251* 12,441 NaN
Loss from equity method investment
-91,582 -234,565* 176,056 NaN
Total other income (expense), net
-46,673 -158,494 NaN -107
Interest income
NaN NaN NaN 8,495
Other income, expense, net
NaN NaN 179,312 NaN
Net loss
-1,150,152 -5,983,321 -1,137,673 -1,537,712
Deemed dividend
NaN 0 21,556,821 NaN
Net gain attributable to common stockholders
NaN -5,983,321 -22,694,494 NaN
Basic EPS
-0.03 -0.143 -1.18 -0.09
Diluted EPS
-0.03 -0.338* -1.18 -0.09
Basic Average Shares
41,941,370 41,870,778 19,274,947 16,986,488
Diluted Average Shares
NaN NaN 19,274,947 16,986,488
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$1,150,152 (35.52%↑ Y/Y)Total operating costs$1,103,479 (-38.87%↓ Y/Y)Total other income(expense), net-$46,673 Interest income$44,909 (309.65%↑ Y/Y)General andadministrative expenses$578,698 (-61.18%↓ Y/Y)Research and developmentexpenses$524,781 (66.91%↑ Y/Y)Loss from equitymethod investment-$91,582

MIRA PHARMACEUTICALS, INC. (MIRA)

MIRA PHARMACEUTICALS, INC. (MIRA)